Robotic seals, conversational AI prompters, and interactive machines are actively being tested on elderly patients at Paris’ Broca Hospital to explore how automation can assist with cognitive stimulation and dementia care. Researchers at the facility are examining whether devices like the NAO robot, the Paro robotic seal, and the Miroki interactive robot can effectively support therapies for patients.
How Therapeutic Robots Are Used at Broca Hospital
At Broca Hospital, machines serve distinct therapeutic functions depending on their design. The NAO robot uses structured questions and exercises to encourage conversation, asking patients to complete familiar proverbs during interactive sessions. Another device, Paro, functions as a therapeutic comfort object. The robotic seal features built-in sensors that react directly to a patient’s physical movements and sounds. Meanwhile, Miroki is built specifically to interact with patients through direct conversation.
Reactions among patients vary significantly. Lea Vecchioni, a psychologist and research engineer at the Broca Living Lab, notes that responses range from absolute amazement to clear rejection. Some residents find it remarkable to see machines they have only watched on television in real life, while others clearly reject the technology entirely. For 72-year-old patient Michele, the experience is unusual but not unsettling, though she admits a preference for human contact.
Did you know? Researchers at the Broca Living Lab are specifically investigating whether these machines can act as facilitators to help patients engage more deeply with speech and language therapy, physiotherapy, and psychomotor rehabilitation.
AI-Powered Personalization in French Care Homes
Beyond hospital walls, similar trials are underway in southern France. At La Septfontoise in Tarn-et-Garonne, care staff are testing Livana, an artificial intelligence system designed to support residents when they experience agitation. The technology operates through a telephone interface, generating personalized conversations tailored to the individual.
Before trials began, staff gathered biographical data—including life stories and personal interests—with the full consent and cooperation of residents’ families. Psychologist Elodie Jammes explains that this background information shapes the voice and content of the AI interactions, utilizing elements that soothe residents based on their specific histories. The system acts as a non-drug approach for individuals living with Alzheimer’s or other neurodegenerative conditions.
Balancing Technology and Human Care in Dementia Support
Facility directors and researchers emphasize that automation is intended to supplement, not supplant, traditional care structures. Ghislaine Verines, director of La Septfontoise, states that the trial aims to explore non-drug approaches that improve resident wellbeing while offering additional support for care staff.
Maribel Pino, a cognitive psychology researcher and research director at the Broca Living Lab, stresses that the role of robotics must remain strictly defined. She asserts that machines should not be considered replacement tools, regardless of how advanced their conversational abilities become. According to Pino, technology cannot provide the essential human relationships that people require, ensuring that human contact remains at the absolute center of care.
Frequently Asked Questions
What do therapeutic robots do in hospitals?
Robots like NAO and Miroki engage patients through conversation, cognitive exercises, and proverbs, while devices like Paro provide therapeutic comfort using movement and sound sensors.
Can AI replace caregivers in dementia care?
How does personalized AI work for agitated residents?
Systems like Livana use biographical details and life stories collected with family consent to generate customized, soothing voice interactions through a telephone interface.
Want to stay informed on the latest developments in healthcare technology and elder care? Subscribe to our newsletter or explore our related articles on medical innovation today.
Keep reading